Literature DB >> 24950801

Synergism between inhibitors of Aurora A and KIF11 overcomes KIF15-dependent drug resistance.

Hoi Tang Ma1, Sergio Erdal1, Shan Huang1, Randy Y C Poon2.   

Abstract

The mitotic kinesin KIF11 (also called Eg5) plays critical roles in spindle functions. Although a number of small-molecule inhibitors of KIF11 are currently in clinical development, drug-resistance could be developed through compensation by another kinesin called KIF15. Using a newly developed infrared-based cell system, we discovered that the effectiveness of one of the latest generations of KIF11 inhibitor (SB743921) could be enhanced with several inhibitors of Aurora A kinase. Evidence including live-cell imaging and isobologram analysis indicated that targeting KIF11 and Aurora A together promoted monoastral spindle formation and mitotic catastrophe synergistically, supporting a model of parallel pathways of centrosome regulation by Aurora A and KIF11. We also developed a KIF15-dependent SB743921-resistance cell model. Significantly, the drug-resistance could also be overcome with Aurora A inhibitors. These results provide a molecular basis for increasing the effectiveness of Aurora A and KIF11 inhibitors and tackling problems of drug resistance.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug screening; Drug-resistance; Eg5; Infrared; Kinesin; Mitosis

Mesh:

Substances:

Year:  2014        PMID: 24950801      PMCID: PMC5528592          DOI: 10.1016/j.molonc.2014.05.007

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  39 in total

1.  Dynein, Lis1 and CLIP-170 counteract Eg5-dependent centrosome separation during bipolar spindle assembly.

Authors:  Marvin E Tanenbaum; Libor Macůrek; Niels Galjart; René H Medema
Journal:  EMBO J       Date:  2008-11-20       Impact factor: 11.598

2.  iRFP is a sensitive marker for cell number and tumor growth in high-throughput systems.

Authors:  Andreas K Hock; Pearl Lee; Oliver Dk Maddocks; Susan M Mason; Karen Blyth; Karen H Vousden
Journal:  Cell Cycle       Date:  2013-10-31       Impact factor: 4.534

3.  Synergism between inhibitors of Aurora A and KIF11 overcomes KIF15-dependent drug resistance.

Authors:  Hoi Tang Ma; Sergio Erdal; Shan Huang; Randy Y C Poon
Journal:  Mol Oncol       Date:  2014-06-02       Impact factor: 6.603

4.  Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1.

Authors:  Lyubomir T Vassilev; Christian Tovar; Shaoqing Chen; Dejan Knezevic; Xiaolan Zhao; Hongmao Sun; David C Heimbrook; Li Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

5.  Overexpression of Eg5 predicts unfavorable prognosis in non-muscle invasive bladder urothelial carcinoma.

Authors:  Sentai Ding; Naidong Xing; Jiaju Lu; Hui Zhang; Koji Nishizawa; Shuai Liu; Xiaodong Yuan; Yejun Qin; Ying Liu; Osuma Ogawa; Hiroyuki Nishiyama
Journal:  Int J Urol       Date:  2011-03-30       Impact factor: 3.369

Review 6.  Kinesins and cancer.

Authors:  Oliver Rath; Frank Kozielski
Journal:  Nat Rev Cancer       Date:  2012-07-24       Impact factor: 60.716

7.  Mechanistic analysis of the mitotic kinesin Eg5.

Authors:  Jared C Cochran; Christopher A Sontag; Zoltan Maliga; Tarun M Kapoor; John J Correia; Susan P Gilbert
Journal:  J Biol Chem       Date:  2004-07-06       Impact factor: 5.157

8.  Kif15 cooperates with eg5 to promote bipolar spindle assembly.

Authors:  Marvin E Tanenbaum; Libor Macůrek; Aniek Janssen; Erica F Geers; Mónica Alvarez-Fernández; René H Medema
Journal:  Curr Biol       Date:  2009-10-08       Impact factor: 10.834

9.  Overexpression of Eg5 causes genomic instability and tumor formation in mice.

Authors:  Andrew Castillo; Herbert C Morse; Virginia L Godfrey; Rizwan Naeem; Monica J Justice
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

10.  The NIMA-family kinase Nek6 phosphorylates the kinesin Eg5 at a novel site necessary for mitotic spindle formation.

Authors:  Joseph Rapley; Marta Nicolàs; Aaron Groen; Laura Regué; M Teresa Bertran; Carme Caelles; Joseph Avruch; Joan Roig
Journal:  J Cell Sci       Date:  2008-11-11       Impact factor: 5.285

View more
  20 in total

1.  Synergism between inhibitors of Aurora A and KIF11 overcomes KIF15-dependent drug resistance.

Authors:  Hoi Tang Ma; Sergio Erdal; Shan Huang; Randy Y C Poon
Journal:  Mol Oncol       Date:  2014-06-02       Impact factor: 6.603

2.  Dual inhibition of Kif15 by oxindole and quinazolinedione chemical probes.

Authors:  Megan E Dumas; Geng-Yuan Chen; Nicole D Kendrick; George Xu; Scott D Larsen; Somnath Jana; Alex G Waterson; Joshua A Bauer; William Hancock; Gary A Sulikowski; Ryoma Ohi
Journal:  Bioorg Med Chem Lett       Date:  2018-12-04       Impact factor: 2.823

3.  Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.

Authors:  Jingjing Li; Myung Jin Hong; Jeremy P H Chow; Wing Yu Man; Joyce P Y Mak; Hoi Tang Ma; Randy Y C Poon
Journal:  Oncotarget       Date:  2015-04-20

4.  Pharmacological inactivation of CHK1 and WEE1 induces mitotic catastrophe in nasopharyngeal carcinoma cells.

Authors:  Joyce P Y Mak; Wing Yu Man; Jeremy P H Chow; Hoi Tang Ma; Randy Y C Poon
Journal:  Oncotarget       Date:  2015-08-28

5.  PLK1 regulates centrosome migration and spindle dynamics in male mouse meiosis.

Authors:  Enrique Alfaro; Pablo López-Jiménez; José González-Martínez; Marcos Malumbres; José A Suja; Rocío Gómez
Journal:  EMBO Rep       Date:  2021-02-21       Impact factor: 8.807

6.  Pharmacological targeting the ATR-CHK1-WEE1 axis involves balancing cell growth stimulation and apoptosis.

Authors:  Joyce P Y Mak; Wing Yu Man; Hoi Tang Ma; Randy Y C Poon
Journal:  Oncotarget       Date:  2014-11-15

Review 7.  Recent findings and future directions for interpolar mitotic kinesin inhibitors in cancer therapy.

Authors:  Stephanie M Myers; Ian Collins
Journal:  Future Med Chem       Date:  2016-03-15       Impact factor: 3.808

8.  A microtubule polymerase cooperates with the kinesin-6 motor and a microtubule cross-linker to promote bipolar spindle assembly in the absence of kinesin-5 and kinesin-14 in fission yeast.

Authors:  Masashi Yukawa; Tomoki Kawakami; Masaki Okazaki; Kazunori Kume; Ngang Heok Tang; Takashi Toda
Journal:  Mol Biol Cell       Date:  2017-10-11       Impact factor: 4.138

9.  Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer.

Authors:  Kayo Daigo; Atsushi Takano; Phung Manh Thang; Yoshihiro Yoshitake; Masanori Shinohara; Iwau Tohnai; Yoshinori Murakami; Jiro Maegawa; Yataro Daigo
Journal:  Int J Oncol       Date:  2017-10-31       Impact factor: 5.650

Review 10.  Evolving Therapeutic Strategies to Exploit Chromosome Instability in Cancer.

Authors:  Laura L Thompson; Lucile M-P Jeusset; Chloe C Lepage; Kirk J McManus
Journal:  Cancers (Basel)       Date:  2017-11-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.